Evidence map›Paper›PMID 35741136›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Breast Cancer Screening Based on Supervised Learning and Multi-Criteria Decision-Making.

Mubarak Taiwo Mustapha, Dilber Uzun Ozsahin, Ilker Ozsahin, Berna Uzun

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. An Alternative Diagnostic Method forDiagnostics (Basel, Switzerland) · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mubarak Taiwo MustaphaDepartment of Biomedical Engineering, Near East University, Mersin 99138, Turkey.ORCID 0000-0001-8653-3809
Dilber Uzun OzsahinDepartment of Medical Diagnostic Imaging, College of Health Science, University of Sharjah, Sharjah 27272, United Arab Emirates.
Ilker OzsahinDepartment of Biomedical Engineering, Near East University, Mersin 99138, Turkey.
Berna UzunDepartment of Statistics, Carlos III University of Madrid, 28903 Getafe, Madrid, Spain.ORCID 0000-0002-6828-2185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On average, breast cancer kills one woman per minute. However, there are more reasons for optimism than ever before. When diagnosed early, patients with breast cancer have a better chance of survival. This study aims to employ a novel approach that combines artificial intelligence and a multi-criteria decision-making method for a more robust evaluation of machine learning models. The proposed machine learning techniques comprise various supervised learning algorithms, while the multi-criteria decision-making technique implemented includes the Preference Ranking Organization Method for Enrichment Evaluations. The Support Vector Machine, having achieved a net outranking flow of 0.1022, is ranked as the most favorable model for the early detection of breast cancer. The net outranking flow is the balance between the positive and negative outranking flows. This indicates that the higher the net flow, the better the alternative. K-nearest neighbor, logistic regression, and random forest classifier ranked second, third, and fourth, with net flows of 0.0316, -0.0032, and -0.0541, respectively. The least preferred alternative is the naive Bayes classifier with a net flow of -0.0766. The results obtained in this study indicate the use of the proposed method in making a desirable decision when selecting the most appropriate machine learning model. This gives the decision-maker the option of introducing new criteria into the decision-making process.

Indexed as

benigndecision-makingmachine learningmalignantsupervised learning

Identifiers

PMID35741136
PMCPMC9221649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.